moksha8 Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:moksha8 Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7567
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Moksha8 Pharmaceuticals Inc (Moksha8) is a specialty pharmaceutical company that offers therapeutic products. The company manufactures and commercializes products for the treatment of critical diseases. It provides vilazodone HCI for depressive disorder. Moksha8 commercialize a portfolio of therapeutics for the treatment of central nervous system and mental health disorders such as depressive disorders, bipolar disorders, schizophrenia, Alzheimer’s disease, and epilepsy; and schizophrenia, bipolar mania, and behavioral symptoms in patients with dementia, and irritability in patients with Autism. The company operates through research laboratories, pharmaceutical and biotechnology companies. It operates offices in Brazil, Mexico and the US. Moksha8 is headquartered in Sao Paulo City, Brazil.

moksha8 Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
moksha8 Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Laboratorios Biopas Enters into Commercialisation Agreement with moksha8 Pharma 11
Licensing Agreements 12
Bial Enters into Licensing Agreement with Moksha8 Pharma for Eslicarbazepine Acetate 12
Forest Labs Amends Licensing Agreement With moksha8 For Viibryd 13
Watson Pharma Enters Into Licensing Agreement With moksha8 Pharma For Five Generic Central Nervous System Products 14
Forest Labs Enters Into Licensing Agreement With moksha8 For Viibryd 15
Acquisition 16
Watson Pharma Sells Minority Stake In moksha8 Pharma For US$47 Million 16
moksha8 Pharmaceuticals Inc – Key Competitors 17
moksha8 Pharmaceuticals Inc – Key Employees 18
moksha8 Pharmaceuticals Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
moksha8 Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
moksha8 Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Laboratorios Biopas Enters into Commercialisation Agreement with moksha8 Pharma 11
Bial Enters into Licensing Agreement with Moksha8 Pharma for Eslicarbazepine Acetate 12
Forest Labs Amends Licensing Agreement With moksha8 For Viibryd 13
Watson Pharma Enters Into Licensing Agreement With moksha8 Pharma For Five Generic Central Nervous System Products 14
Forest Labs Enters Into Licensing Agreement With moksha8 For Viibryd 15
Watson Pharma Sells Minority Stake In moksha8 Pharma For US$47 Million 16
moksha8 Pharmaceuticals Inc, Key Competitors 17
moksha8 Pharmaceuticals Inc, Key Employees 18
moksha8 Pharmaceuticals Inc, Other Locations 19

List of Figures
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
moksha8 Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
moksha8 Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[moksha8 Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cell Therapy Catapult Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Cell Therapy Catapult Ltd (Catapult) is a provider of cell and gene therapy life cycle solutions. The company offers services such as industrialization, manufacturing, regulatory, health economics and market access, non-clinical safety and clinical operations. Its health economics and market …
  • Lietuvos energijos gamyba, AB (LNR1L):電力:M&Aディール及び事業提携情報
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Petrol dd Ljubljana (PETG):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrol dd Ljubljana (Petrol dd) is an energy company. It markets and distributes oil and petroleum products, electricity, heat, merchandise, natural gas and liquefied petroleum gas (LPG). The company sells automotive products, foodstuffs, accessories, tobacco, and chemical products. Petrol d …
  • The AES Corporation (AES):電力:M&Aディール及び事業提携情報
    Summary The AES Corporation (AES) is a diversified power company, which owns and operates power generating facilities. The company generates electricity through diverse fuel sources such as gas, fuel oil and coal; and renewable sources such as wind, hydro, biomass and solar. It sells the electricity …
  • Allied International Corporation:企業の戦略・SWOT・財務情報
    Allied International Corporation - Strategy, SWOT and Corporate Finance Report Summary Allied International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Seabridge Gold Inc.:企業のM&A・事業提携・投資動向
    Seabridge Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Seabridge Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Intas Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropo …
  • Thomas Cook Group plc (TCG):企業の財務・戦略的SWOT分析
    Thomas Cook Group plc (TCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Idexx Laboratories Inc (IDXX):企業の財務・戦略的SWOT分析
    Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Monsoon Accessorize Ltd:企業の戦略・SWOT・財務分析
    Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report Summary Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Second Sight Medical Products Inc (EYES):企業の財務・戦略的SWOT分析
    Summary Second Sight Medical Products Inc (Second Sight) is a medical device company. It develops, manufactures and markets implantable visual prosthetics for blind individuals. The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering …
  • CellSeed Inc (7776):企業の財務・戦略的SWOT分析
    Summary CellSeed Inc (CellSeed) is a developer of regenerative medicine. The company’s products include epithelial cell sheet for corneal regeneration, regenerated cardiac patch, epithelial cell sheet for esophageal regeneration, cell sheet for periodontal tissue regeneration and regenerated cartila …
  • Banco General SA:企業の戦略・SWOT・財務情報
    Banco General SA - Strategy, SWOT and Corporate Finance Report Summary Banco General SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Air Total International SA:企業の戦略的SWOT分析
    Air Total International SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • J.W. Ostendorf GmbH & Co KG:企業の戦略・SWOT・財務情報
    J.W. Ostendorf GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary J.W. Ostendorf GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • President Energy PLC (PPC):石油・ガス:M&Aディール及び事業提携情報
    Summary President Energy PLC (President) is an independent oil and gas exploration and production company. It focuses mainly on Argentina and Paraguay in South America. The company has a diverse portfolio of operated onshore producing and exploration assets. Its major assets include working interest …
  • Steelcase Inc (SCS):企業の財務・戦略的SWOT分析
    Steelcase Inc (SCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Check Point Software Technologies Ltd.:企業の戦略・SWOT・財務情報
    Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report Summary Check Point Software Technologies Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Henry Lamotte Group:戦略・SWOT・企業財務分析
    Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report Summary Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aqua Bio Technology ASA (ABT):企業の財務・戦略的SWOT分析
    Summary Aqua Bio Technology ASA (ABT) is a biotechnology company that develops, produces and markets new active ingredients. The company’s products comprise Aquabeautine XL and Smids. Its product Aquabeautine XL is derived from the hatching fluid of salmon. ABT’s products are based on research and d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆